MISSIONPHARMA GROUP ApS: Financial statements 2013
CVR: 29782792
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
MISSIONPHARMA GROUP ApS (CVR 29782792) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -122,000 and a net result of DKK 39,425,000. Equity in the 2013 report amounted to DKK 239,453,000. The solvency ratio was 98.8%. The company had 104 employees in the financial year.
- Revenue
- DKK 0
- Gross Profit
- DKK -122,000
- Profit/Loss
- DKK 39,425,000
- Equity
- DKK 239,453,000
- Total Assets
- DKK 242,283,000
- Employees
- 104
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
MISSIONPHARMA GROUP ApS has published its interim report for the period May 1, 2012 – December 31, 2012.
As of March 15, 2013, Kim Erik Ginnerup is registered as adm. dir. of MISSIONPHARMA GROUP ApS.
As of March 15, 2013, Mikkel Mørkedal Wakefield has stepped down as adm. dir. of MISSIONPHARMA GROUP ApS.
On February 21, 2013, the company changed its name from MIFAMED HOLDING ApS to MISSIONPHARMA GROUP ApS.
About MISSIONPHARMA GROUP ApS
MISSIONPHARMA GROUP ApS was a Danish company of the type Anpartsselskab based in Lynge, founded in 2006. The company has been dissolved on 15 December 2023. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named MIFAMED HOLDING ApS and MISSIONPHARMA HOLDING ApS. According to the 2023 annual report, the company had an average of 150 employees. In 2023, the company reported a gross profit of DKK -110,000 and a net result of DKK 118,139,000 compared with DKK 52,312,000 the year before. Equity in the 2023 report amounted to DKK 349,722,000.